Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Sunday, May 11th 2025, 10:01:46 pm
article
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds (15 kilograms).
Breaking
President Trump Endorses Jack Ciattarelli for governor of New Jersey calling him "a winner" amid past criticism....
The Boston Celtics lost both Jayson Tatum and Game 4 on Monday night after squandering yet another double-digit lead to the New York Knicks....
